Hypoallergenic Infant Formula Market Set to Hit $8.2B by 2032 Amid Specialized Nutrition Surge
Hypoallergenic Infant Formula Market 2025
Global hypoallergenic infant formula market grows rapidly, fueled by specialized formulas, amino-acid-based products, and rising allergy awareness.
Hypoallergenic infant formulas are transforming infant nutrition, offering safe, clinically backed options for children with allergies or sensitivities.”
LOS ANGELES, CA, UNITED STATES, October 24, 2025 /EINPresswire.com/ -- The Global Hypoallergenic Infant Formula Market reached US$ 3.9 billion in 2023, grew to US$ 4.3 billion in 2024, and is projected to reach US$ 8.2 billion by 2032, registering a CAGR of 8.5% during the forecast period 2025โ2032.— DataM Intelligence
Top Key Players: Nestlรฉ, Abbott, Danone, Reckitt Benckiser Group plc, Perrigo, HiPP, Meiji Holdings Co., Ltd, Arla Foods Ingredients Group, FrieslandCampina, Hero Baby.
๐๐ฒ๐ ๐ฎ ๐ฆ๐ฎ๐บ๐ฝ๐น๐ฒ ๐ฃ๐๐ ๐๐ฟ๐ผ๐ฐ๐ต๐๐ฟ๐ฒ ๐ผ๐ณ ๐๐ต๐ฒ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ (๐จ๐๐ฒ ๐๐ผ๐ฟ๐ฝ๐ผ๐ฟ๐ฎ๐๐ฒ ๐๐บ๐ฎ๐ถ๐น ๐๐ ๐ณ๐ผ๐ฟ ๐ฎ ๐ค๐๐ถ๐ฐ๐ธ ๐ฅ๐ฒ๐๐ฝ๐ผ๐ป๐๐ฒ): https://www.datamintelligence.com/download-sample/hypoallergenic-infant-formula-market
United States โ Industry News
โ Product Launch: On April 20, 2025, Abbott launched EleCare Jr with DHA & Lutein, an amino acid-based medical food designed for children with serious food allergies and gastrointestinal disorders.
โ Regulatory Initiative: On May 13, 2025, the FDA issued a Request for Information to begin the nutrient review process for infant formula, aiming to ensure nutritional adequacy and safety.
โ Danone Acquires Kate Farms - In May 2025, Danone acquired a majority stake in Kate Farms, a U.S.-based producer of plant-based organic nutritional drinks. This acquisition aims to enhance Danone's specialized nutrition portfolio and expand its presence in the U.S. medical nutrition market.
โ Bobbie Acquires Natureโs One - In July 2023, Bobbie, a U.S.-based infant formula company, acquired Natureโs One for an undisclosed amount. This acquisition aims to enhance its product offerings and strengthen its position in the organic infant formula market with the addition of manufacturing facilities.
Japan โ Industry News
โ Product Launch: In April 2025, Abbott launched EleCare Jr with DHA & Lutein in Japan, an amino acid-based medical food designed for children with serious food allergies and gastrointestinal disorders.
Looking For A Detailed Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=hypoallergenic-infant-formula-market
Market Segments:
โข By Product Type - Extensively Hydrolyzed Formula (eHF), Amino Acid-Based Formula (AAF), Partially Hydrolyzed Formula (pHF)
โข By Form โ Powder, Liquid (Ready-to-Feed)
โข By Distribution Channel - Online, Offline
Key Product Segments
โข Extensively Hydrolyzed Formulas (eHF): These formulas are designed for infants with moderate to severe CMPA. They dominate the market due to their clinical effectiveness and medical recommendations.
โข Amino Acid-Based Formulas (AAF): Suitable for infants with severe allergies or multiple food protein intolerances, AAFs provide complete nutrition through free amino acids, minimizing allergenic risks.
โข Other Specialized Formulas: Includes partially hydrolyzed formulas and soy-based formulas, catering to infants with milder allergies or sensitivities.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/hypoallergenic-infant-formula-market
Regional Insights
โข North America: Led the global market with a share of 37.6% in 2024, driven by high awareness of infant nutrition and a preference for specialized formulas.
โข Asia-Pacific: Expected to witness the fastest growth due to increasing awareness of infant nutritional requirements, urbanization, and changing lifestyles. Countries like China and India are experiencing rising demand for hypoallergenic formulas.
โข Europe: Experiencing steady growth, supported by national screening programs and a shift towards personalized infant nutrition.
Related Reports:
Organic Infant Formula Market
Probiotic Infant Formula Market
Kailas Disale
DataM Intelligence 4market Research LLP
+1 877-441-4866
kailas@datamintelligence.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
